The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 278-285 , March 2010

Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation

  • Jeremiah G. Allen, MD

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University Medical Institutions, Baltimore, Maryland
    • ,
  • Eric S. Weiss, MD

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University Medical Institutions, Baltimore, Maryland
    • ,
  • Justin M. Schaffer, MS

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University Medical Institutions, Baltimore, Maryland
    • ,
  • Nishant D. Patel, BA

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University Medical Institutions, Baltimore, Maryland
    • ,
  • Susan L. Ullrich, RN

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University Medical Institutions, Baltimore, Maryland
    • ,
  • Stuart D. Russell, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, The Johns Hopkins University Medical Institutions, Baltimore, Maryland
    • ,
  • Ashish S. Shah, MD

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University Medical Institutions, Baltimore, Maryland
    • ,
  • John V. Conte, MD

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University Medical Institutions, Baltimore, Maryland
    • Corresponding Author InformationReprint requests: John V. Conte, MD, Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University Medical Institutions, 600 North Wolfe Street, Blalock 618, Baltimore, MD 21287. Telephone: 410-955-1753. Fax: 410-955-3809

References 

  1. American Heart Association. Heart disease and stroke statistics, 2009 update. Dallas, TX: American Heart Association; 2009;
  2. Effects of enalapril on mortality in severe congestive heart failure (Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)). N Engl J Med. 1987;316:1429–1435
  3. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402
  4. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344–350
  5. Feller ED, Sorensen EN, Haddad M, et al. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. Ann Thorac Surg. 2007;83:1082–1088
  6. John R, Kamdar F, Liao K, et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg. 2008;86:1227–1234
  7. Garatti A, Bruschi G, Colombo T, et al. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices. Eur J Cardiothorac Surg. 2008;34:275–280
  8. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  9. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129:9–17
  10. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741–747
  11. Oz MC, Gelijns AC, Miller L, et al. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg. 2003;238:577–583
  12. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497–505
  13. Clegg AJ, Scott DA, Loveman E, et al. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Health Technol Assess (Winchester, England). 2005;9:1–132
  14. Grady KL, Meyer P, Mattea A, et al. Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transplant. 2001;20:657–669
  15. Grady KL, Meyer PM, Mattea A, et al. Change in quality of life from before to after discharge following left ventricular assist device implantation. J Heart Lung Transplant. 2003;22:322–333
  16. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–896
  17. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312–321
  18. Grady KL, Meyer PM, Dressler D, et al. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Ann Thorac Surg. 2004;77:1321–1327
  19. Wray J, Hallas CN, Banner NR. Quality of life and psychological well-being during and after left ventricular assist device support. Clin Transplant. 2007;21:622–627
  20. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124:1017–1025
  21. Rector TS. Minnesota Living with Heart Failure Questionnaire. www.mlhfq.org2005;(accessed April 1, 2009)
  22. MacIver J, Rao V, Delgado DH, et al. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure. J Heart Lung Transplant. 2008;27:1002–1007
  23. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71:1106–1107
  24. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132:919–923
  25. Enright PL. The six-minute walk test. Respir Care. 2003;48:783–785
  26. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384–1387
  27. ATS statement (Guidelines for the six-minute walk test). Am J Respir Crit Care Med. 2002;166:111–117
  28. Demers C, McKelvie RS, Negassa A, et al. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J. 2001;142:698–703
  29. Alahdab MT, Mansour IN, Napan S, et al. Six minute walk test predicts long-term all-cause mortality and heart failure rehospitalization in African-American patients hospitalized with acute decompensated heart failure. J Card Fail. 2009;15:130–135
  30. Ainsworth BE, Haskell WL, Leon AS, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71–80
  31. Hernandez AF, Shea AM, Milano CA, et al. Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA. 2008;300:2398–2406
  32. Hutchinson J, Scott DA, Clegg AJ, et al. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure. Exp Rev Cardiovasc Ther. 2008;6:175–185
  33. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270:1702–1707
  34. Cahalin LP, Mathier MA, Semigran MJ, et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest. 1996;110:325–332
  35. Peeters P, Mets T. The 6-minute walk as an appropriate exercise test in elderly patients with chronic heart failure. J Gerontol. 1996;51:M147–M151
  36. Maurer MS, Cuddihy P, Weisenberg J, et al. The prevalence and impact of anergia (lack of energy) in subjects with heart failure and its associations with actigraphy. J Card Fail. 2009;15:145–151
  37. Balashov K, Feldman DE, Savard S, et al. Percent predicted value for the 6-minute walk test: using norm-referenced equations to characterize severity in persons with CHF. J Card Fail. 2008;14:75–81
  38. Rector TS, Tschumperlin LK, Kubo SH, et al. Use of the Living with Heart Failure Questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1995;1:201–206
  39. Kubo SH, Schulman S, Starling RC, et al. Development and validation of a patient questionnaire to determine New York Heart Association classification. J Card Fail. 2004;10:228–235
  40. Helman DN, Oz MC. Developing a comprehensive mechanical support program. J Card Surg. 2001;16:203–208
  41. John R. Current axial-flow devices—the HeartMate II and Jarvik 2000 left ventricular assist devices. Sem Thorac Cardiovasc Surg. 2008;20:264–272
  42. Kamdar F, Boyle A, Liao K, et al. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant. 2009;28:352–359
  43. Zierer A, Melby SJ, Voeller RK, et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007;84:515–520

PII: S1053-2498(09)00613-5

doi: 10.1016/j.healun.2009.07.017

The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 278-285 , March 2010

Article Tools